3 ms·

Hospitalization from COVID-19

• mmastrac 5y ago
  Funny that we just assume that anyways these days.
• loeg 5y ago
  The full article title is: Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study The HN one is somewhat arbidged.
• javierbyte 5y ago
  I had to check the title to make sure it is not there. I totally read "from COVID-19" in my mind.
• hncurious 5y ago
  There's a joke in here about the conflation of the data all throughout the pandemic and how there's been a failure to differentiate between with Covid and from Covid. https://www.theatlantic.com/health/archive/2021/09/covid-hospitalization-numbers-can-be-misleading/620062/ https://www.theatlantic.com/health/archive/2021/09/covid-hos...
  • shusaku 5y ago
    There’s maybe an amusing counter point from this study. Here they ran a trial with a highly at risk population (due to comorbidities) and reduced hospitalization by 50%. I guess it’s possible the drug is 100% effective and the hospitalization of the remainder were driven by other factors, but even in that case you’d be overestimating hospitalization by just a factor of two. And since none of the people who received the drug died, I guess it’s good indirect evidence that we’re counting covid deaths among the high risk, diagnosed population reasonably well?